Cargando…

Control of STING Agonistic/Antagonistic Activity Using Amine-Skeleton-Based c-di-GMP Analogues

Stimulator of Interferon Genes (STING) is a type of endoplasmic reticulum (ER)-membrane receptor. STING is activated by a ligand binding, which leads to an enhancement of the immune-system response. Therefore, a STING ligand can be used to regulate the immune system in therapeutic strategies. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yanase, Yuta, Tsuji, Genichiro, Nakamura, Miki, Shibata, Norihito, Demizu, Yosuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224868/ https://www.ncbi.nlm.nih.gov/pubmed/35743289 http://dx.doi.org/10.3390/ijms23126847

Ejemplares similares

Development of ciclesonide analogues that block SARS-CoV-2 RNA replication
por: Tsuji, Genichiro, et al.
Publicado: (2021)

Peptide nanotube loaded with a STING agonist, c-di-GMP, enhance cancer immunotherapy against melanoma
por: Zhang, Ziyuan, et al.
Publicado: (2022)

STING is a direct innate immune sensor of cyclic-di-GMP
por: Burdette, Dara L., et al.
Publicado: (2011)

Inhibition of P. aeruginosa c-di-GMP phosphodiesterase RocR and swarming motility by a benzoisothiazolinone derivative
por: Zheng, Yue, et al.
Publicado: (2016)

Development of Agonist-Based PROTACs Targeting Liver X Receptor
por: Xu, Hanqiao, et al.
Publicado: (2021)

Extent of Helical Induction Caused by Introducing α-Aminoisobutyric Acid into an Oligovaline Sequence
por: Tsuji, Genichiro, et al.
Publicado: (2018)

STING Agonists/Antagonists: Their Potential as Therapeutics and Future Developments
por: Guerini, Danilo
Publicado: (2022)

Structure of STING bound to c-di-GMP Reveals the Mechanism of Cyclic Dinucleotide Recognition by the Immune System
por: Shu, Chang, et al.
Publicado: (2012)

Endo-S-c-di-GMP Analogues-Polymorphism and Binding Studies with Class I Riboswitch
por: Zhou, Jie, et al.
Publicado: (2012)

STING Agonists as Cancer Therapeutics
por: Amouzegar, Afsaneh, et al.
Publicado: (2021)

Targeted Protein Degradation by Chimeric Compounds using Hydrophobic E3 Ligands and Adamantane Moiety
por: Shoda, Takuji, et al.
Publicado: (2020)

Cyclic-di-GMP Induces STING-Dependent ILC2 to ILC1 Shift During Innate Type 2 Lung Inflammation
por: Cavagnero, Kellen J., et al.
Publicado: (2021)

Design, Synthesis, and Biochemical and Biological Evaluation of Novel 7-Deazapurine Cyclic Dinucleotide Analogues as STING Receptor Agonists
por: Vavřina, Zdeněk, et al.
Publicado: (2022)

Biofilms and Cyclic di-GMP (c-di-GMP) Signaling: Lessons from Pseudomonas aeruginosa and Other Bacteria
por: Valentini, Martina, et al.
Publicado: (2016)

STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS)
por: Messaoud-Nacer, Yasmine, et al.
Publicado: (2022)

Antiviral activity of ciclesonide acetal derivatives blocking SARS-CoV-2 RNA replication
por: Tsuji, Genichiro, et al.
Publicado: (2022)

Polarity of c-di-GMP synthesis and degradation
por: Kreiling, Vanessa, et al.
Publicado: (2023)

Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
por: Chang, Jiajia, et al.
Publicado: (2023)

Trial watch: STING agonists in cancer therapy
por: Le Naour, Julie, et al.
Publicado: (2020)

Identification and Characterization of c-di-GMP Metabolic Enzymes of Leptospira interrogans and c-di-GMP Fluctuations After Thermal Shift and Infection
por: Xiao, Guohui, et al.
Publicado: (2018)

Terrein is an inhibitor of quorum sensing and c-di-GMP in Pseudomonas aeruginosa: a connection between quorum sensing and c-di-GMP
por: Kim, Bomin, et al.
Publicado: (2018)

Reciprocal c-di-GMP signaling: Incomplete flagellum biogenesis triggers c-di-GMP signaling pathways that promote biofilm formation
por: Wu, Daniel C., et al.
Publicado: (2020)

Effects of STING stimulation on macrophages: STING agonists polarize into “classically” or “alternatively” activated macrophages?
por: Ohkuri, Takayuki, et al.
Publicado: (2017)

ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance
por: Jang, Su Chul, et al.
Publicado: (2021)

Nitric oxide regulated cyclic di-GMP signaling
por: Boon, Elizabeth M, et al.
Publicado: (2013)

Cyclic di-GMP signalling and the regulation of bacterial virulence
por: Ryan, Robert P.
Publicado: (2013)

Visualization of c-di-GMP in multicellular Dictyostelium stages
por: Ide, Hayato, et al.
Publicado: (2023)

Design, Synthesis, and Biological Activity of Conformationally Restricted Analogues of Silibinin
por: Mizuno, Mirei, et al.
Publicado: (2020)

Induction of the acrosome reaction in guinea pig spermatozoa by cGMP analogues
Publicado: (1980)

New cGMP analogues restrain proliferation and migration of melanoma cells
por: Vighi, Eleonora, et al.
Publicado: (2017)

In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera
por: Guillemyn, Karel, et al.
Publicado: (2012)

Mechanism of activation of bacterial cellulose synthase by cyclic-di-GMP
por: Morgan, Jacob L. W., et al.
Publicado: (2014)

Cyclic di-GMP regulates Mycobacterium tuberculosis resistance to ethionamide
por: Zhang, Hai-Nan, et al.
Publicado: (2017)

Pleiotropic Effects of c-di-GMP Content in Pseudomonas syringae
por: Wang, Tingting, et al.
Publicado: (2019)

c-di-GMP Inhibits Early Sporulation in Clostridioides difficile
por: Edwards, Adrianne N., et al.
Publicado: (2021)

2′-Fluoro-c-di-GMP as an oral vaccine adjuvant
por: Li, Jia, et al.
Publicado: (2019)

Impact of c-di-GMP on the Extracellular Proteome of Rhizobium etli
por: Lorite, María J., et al.
Publicado: (2022)

Development of Rapid and Facile Solid‐Phase Synthesis of PROTACs via a Variety of Binding Styles
por: Xu, Hanqiao, et al.
Publicado: (2022)

The Streptomyces master regulator BldD binds c-di-GMP sequentially to create a functional BldD(2)-(c-di-GMP)(4) complex
por: Schumacher, Maria A., et al.
Publicado: (2017)

Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
por: Motedayen Aval, Leila, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m3j0aefqmt7v7grl017nbnpuke